PR Newswire
ST. LOUIS, Feb. 8, 2022
ST. LOUIS, Feb. 8, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the fourth quarter and year ended December 31, 2021, reporting diluted earnings per share (EPS) of $1.01 and $2.28, respectively, and adjusted diluted EPS of $1.01 and $5.15, respectively.
In summary, the 2021 fourth quarter and full year results were as follows:
2021 Results | |||
| Q4 | | Full Year |
Total revenues (in millions) | $ 32,568 | | $ 125,982 |
Premium and service revenues (in millions) | $ 30,493 | | $ 117,983 |
Health benefits ratio | 87.9% | | 87.8% |
SG&A expense ratio | 9.3% | | 8.6% |
Adjusted SG&A expense ratio (1) | 9.2% | | 8.4% |
GAAP diluted EPS | $ 1.01 | | $ 2.28 |
Adjusted diluted EPS (1) | $ 1.01 | | $ 5.15 |
Total cash flow provided by operations (in millions) | $ 675 | | $ 4,205 |
| |||
(1) A full reconciliation of the adjusted SG&A expense ratio and adjusted diluted EPS is shown beginning on page 7 of this release. |
"We ended 2021 with strong fourth quarter results at the high end of our previously provided earnings guidance range. Our portfolio is performing well as we executed across our three major product lines, building on our strong foundation and extending our market-leading position in government sponsored healthcare," said Michael F. Neidorff, Chairman and Chief Executive Officer of Centene. "As we look ahead, we are focused on advancing initiatives across the enterprise to deliver on our value creation goals and 2022 operational objectives."
Fourth Quarter and Full Year Highlights
Other Events
Accreditations & Awards
Membership
The following table sets forth our membership by line of business:
| December 31, | ||
| 2021 | | 2020 |
Traditional Medicaid (1) | 13,328,400 | | 12,055,400 |
High Acuity Medicaid (2) | 1,686,100 | | 1,554,700 |
Total Medicaid | 15,014,500 | | 13,610,100 |
Commercial | 2,602,600 | | 2,633,600 |
Medicare (3) | 1,252,200 | | 955,400 |
Medicare PDP | 4,070,500 | | 4,469,400 |
International | 597,600 | | 597,700 |
Correctional | 194,500 | | 147,200 |
Total at-risk membership | 23,731,900 | | 22,413,400 |
TRICARE eligibles | 2,874,700 | | 2,877,900 |
Non-risk membership | 4,000 | | 231,600 |
Total | 26,610,600 | | 25,522,900 |
| |||
(1) Membership includes TANF, Medicaid Expansion, CHIP, Foster Care and Behavioral Health. | |||
(2) Membership includes ABD, IDD, LTSS and MMP Duals. | |||
(3) Membership includes Medicare Advantage and Medicare Supplement. |
The following table sets forth additional membership statistics, which are included in the membership information above:
| December 31, | ||
| 2021 | | 2020 |
Dual-eligible (4) | 1,178,000 | | 1,066,800 |
Health Insurance Marketplace | 2,140,500 | | 2,131,600 |
Medicaid Expansion | 2,468,100 | | 2,181,400 |
| |||
(4) Membership that is eligible for both Medicaid and Medicare benefits. |
Revenues
The following table sets forth supplemental revenue information ($ in millions):
| Three Months Ended December 31, | | Year Ended December 31, | ||||||||
| 2021 | | 2020 Werbung Mehr Nachrichten zur Centene Corp. Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News |